Duration of anticoagulation in venous thromboembolism
- PMID: 12796061
- DOI: 10.1001/archinte.163.11.1265
Duration of anticoagulation in venous thromboembolism
Comment on
-
The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis.Arch Intern Med. 2003 Jun 9;163(11):1285-93. doi: 10.1001/archinte.163.11.1285. Arch Intern Med. 2003. PMID: 12796064
Similar articles
-
The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis.Arch Intern Med. 2003 Jun 9;163(11):1285-93. doi: 10.1001/archinte.163.11.1285. Arch Intern Med. 2003. PMID: 12796064
-
Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism.Br J Haematol. 2005 Feb;128(4):513-9. doi: 10.1111/j.1365-2141.2004.05348.x. Br J Haematol. 2005. PMID: 15686461
-
[Duration of antivitamin K therapy in venous thromboembolic disease].Arch Mal Coeur Vaiss. 1995 Dec;88(12):1891-4. Arch Mal Coeur Vaiss. 1995. PMID: 8729371 Review. French.
-
Recurrent thromboembolism after treatment with vitamin K antagonists.Arch Intern Med. 2003 Dec 8-22;163(22):2793. doi: 10.1001/archinte.163.22.2793-a. Arch Intern Med. 2003. PMID: 14662641 No abstract available.
-
[Hemorrhagic complications of anti-vitamin K treatments].J Mal Vasc. 1995;20(2):95-101. J Mal Vasc. 1995. PMID: 7650448 Review. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical